Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

SNOA
Sonoma Pharmaceuticals, Inc. Common Stock
stock NASDAQ

At Close
Oct 24, 2025 3:58:30 PM EDT
3.92USD+6.522%(+0.24)13,112
0.00Bid   0.00Ask   0.00Spread
Pre-market
0.00USD-100.000%(-3.68)0
After-hours
Oct 23, 2025 4:10:30 PM EDT
4.00USD+8.696%(+0.32)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 21, 2022
08:08AM EST  The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective   Benzinga
05:21AM EST  Sonoma Pharmaceuticals Announces Expansion Of It's Partner Network For Oral And Dental Products In U.S. And China   Benzinga
Jan 20, 2022
04:40PM EST  Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China   Business Wire
Jan 5, 2022
04:55PM EST  Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022   Business Wire
Nov 15, 2021
11:11AM EST  Sonoma Pharmaceuticals Q2 EPS $(0.04) Down From $0.08 YoY, Sales $3.74M Down From $5.77M YoY   Benzinga
08:13AM EST  Sonoma Pharmaceuticals Q3 Net Loss From Cont. Ops. $95K Vs Net Income $151K Last Year   RTTNews
08:00AM EST  Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results   Business Wire
Nov 9, 2021
11:31AM EST  Sonoma Pharmaceuticals And Dyamed Biotech Announce Expanded Long-Term Partnership For New Territories And Products In Southeast Asia   Benzinga
Oct 15, 2021
07:44AM EDT  The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO   Benzinga
07:25AM EDT  Nanocyn Disinfectant & Sanitizer has been approved by the Australian Therapeutic Goods Administration with a 15 second SARS-CoV-2 (COVID-19) kill time, Sonoma Pharmaceuticals Inc. (SNOA) and its partner, the MicroSafe Group said in a statement.   RTTNews
07:06AM EDT  Sonoma : Nanocyn Disinfectant & Sanitizer Approved By Australia TGA With 15 Second SARS-CoV-2 Kill Time; Stock Up   RTTNews
07:04AM EDT  Sonoma Pharma, MicroSafe Report Nanocyn Disinfectant, Sanitzer Has Been Approved By Australia Therapeutic Goods Admin.   Benzinga
07:00AM EDT  Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(r) Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill Time   Business Wire
Sep 28, 2021
02:37PM EDT  Mid-Afternoon Market Update: Dow Tumbles 500 Points; Sonoma Pharmaceuticals Shares Spike Higher   Benzinga
12:05PM EDT  Mid-Day Market Update: Nasdaq Down 2.5%; IHS Markit Posts Upbeat Earnings   Benzinga
10:36AM EDT  Shares of nano-cap company Sonoma Pharmaceuticals, Inc. (SNOA) are surging over 37% on Tuesday morning after the company announced the launch of its first over-the-counter products in the U.S. on Amazon and a new consumer-focused product on Amazon in Europe.   RTTNews
08:18AM EDT  The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive   Benzinga
08:16AM EDT  The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments   Benzinga
07:22AM EDT  Sonoma Pharmaceuticals Highlights Launch Of Over-the-Counter Products In US On Amazon   Benzinga
07:00AM EDT  Sonoma Pharmaceuticals Launches Its First Over-the-Counter Products in the U.S. on Amazon and a New Consumer-Focused Product on Amazon in Europe   Business Wire
Sep 21, 2021
08:20AM EDT  The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data   Benzinga
Sep 17, 2021
07:36AM EDT  The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold   Benzinga
Sep 16, 2021
07:48AM EDT  The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study   Benzinga
Aug 20, 2021
12:20PM EDT  Why Sonoma Pharmaceuticals Shares Are Trading Lower Today   Benzinga
06:03AM EDT  Pre-market Movers: GOVX, PROG, SONN, MRIN,   RTTNews
Aug 19, 2021
02:46PM EDT  Mid-Afternoon Market Update: Dow Falls 170 Points; DLocal Shares Spike Higher   Benzinga
01:20PM EDT  Why Sonoma Pharmaceuticals Shares Are Surging Higher Today   Benzinga
12:20PM EDT  Mid-Day Market Update: Macy's Jumps After Q2 Results; PharmaCyte Biotech Shares Drop   Benzinga
10:20AM EDT  Mid-Morning Market Update: Markets Mostly Flat; Este Lauder Sales Top Views   Benzinga
07:18AM EDT  Sonoma Pharma Launches Two New Dental Products: OroGenix Oral Hygiene Rinse, Microdacyn Oral Care   RTTNews
07:00AM EDT  Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland   Business Wire
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 16, 2021
04:45PM EDT  Sonoma Pharmaceuticals Q1 EPS $(0.52) Down From $(0.38) YoY, Sales $3.68M Down From $5.77M YoY   Benzinga
04:15PM EDT  Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results   Business Wire
Jul 21, 2021
07:52AM EDT  The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay   Benzinga
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jul 16, 2021
07:37AM EDT  The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study   Benzinga
Jul 15, 2021
12:08PM EDT  Sonoma Pharmaceuticals Late Yesterday Reported Q4 EPS $(1.64) Down From $(0.77) YoY, Sales $2.16M Down From $4.58M YoY   Benzinga
Jul 14, 2021
08:58PM EDT  Sonoma Pharma Q4 Total Revenue $2.2 Mln, Decreases By $2.1 Mln Or 50% From Last Year   RTTNews
07:56PM EDT  Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results   Business Wire
Apr 1, 2021
07:46AM EDT  The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract   Benzinga
07:17AM EDT  Sonoma Pharma Stock Is Trading Higher After Distribution Pact With EMC Pharma   Benzinga
Mar 31, 2021
04:11PM EDT  Sonoma Pharmaceuticals And EMC Pharma Announce Exclusive Partnership To Expand Commercial Channels Of The Microcyn-Based Rx Dermatology And Eye Care Products Nationwide; Financial Details Not Disclosed   Benzinga
04:10PM EDT  Sonoma Pharmaceuticals and EMC Pharma Announce an Exclusive Partnership to Expand Commercial Channels of the Microcyn(r)-based Rx Dermatology and Eye Care Products Nationwide   Business Wire
Mar 4, 2021
05:03PM EST  Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences   Business Wire
Feb 16, 2021
05:34PM EST  Sonoma Pharmaceuticals Q3 EPS $(0.32) Up From $(0.72) YoY, Sales $4.90M Up From $4.68M YoY   Benzinga
05:30PM EST  Sonoma Pharmaceuticals Reports Third Quarter FY 2021 Financial Results   Business Wire
Feb 15, 2021
03:45PM EST  WHY:Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) resulting from allegations that Sonoma may have issued materially misleading business information to the investing public.   GlobeNewswire Inc
Feb 2, 2021
08:00AM EST  Investors can contact the law firm at no cost to learn more about recovering their losses   GlobeNewswire Inc
Feb 1, 2021
03:48PM EST  Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm   PR Newswire
Jan 28, 2021
04:36PM EST  Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn(r) Disinfecting Solution is Now Available in Hong Kong and Thailand   Business Wire
Jan 18, 2021
06:00PM EST  ROSEN, GLOBAL INVESTOR COUNSEL, Continues To Investigate Securities Claims   PR Newswire
Jan 11, 2021
05:30PM EST  Sonoma Pharmaceuticals to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference   Business Wire
Dec 19, 2020
11:35PM EST  Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. (Sonoma or the Company) (NASDAQ: SNOA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Dec 17, 2020
06:17PM EST  Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) resulting from allegations that Sonoma may have issued materially misleading business information to the investing public.   GlobeNewswire Inc
04:11PM EST  Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets   Benzinga
Dec 12, 2020
08:08PM EST  Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. (Sonoma or the Company) (NASDAQ: SNOA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Dec 11, 2020
02:30PM EST  Mid-Afternoon Market Update: Dow Turns Higher; Nabriva Therapeutics Shares Slide   Benzinga
12:14PM EST  Mid-Day Market Update: Nasdaq Tumbles 100 Points; Sonoma Pharmaceuticals Shares Surge   Benzinga
10:19AM EST  Mid-Morning Market Update: Markets Edge Lower; Pfizer Coronavirus Vaccine Receives FDA Panel's Nod   Benzinga
09:48AM EST  Shares of Sonoma Pharmaceuticals, Inc. (SNOA) are surging over 100% on Friday morning. The pharma company has teamed up with Crown Laboratories to launch Microcyn technology-based anti-itch over-the-counter products.   RTTNews
08:11AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street   Benzinga
Dec 10, 2020
04:10PM EST  Sonoma Pharma Reports Exclusive Partnership With Crown Labs To Launch Microcyne Technology-Based Anti-Itch OTC Products   Benzinga
04:10PM EST  Sonoma Pharmaceuticals and Crown Laboratories Announce an Exclusive Partnership to Launch Microcyn(r) Technology-Based Anti-Itch Over-the-Counter Products   Business Wire
Dec 7, 2020
08:13PM EST  Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. (Sonoma or the Company) (NASDAQ: SNOA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Dec 2, 2020
09:25AM EST  Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) resulting from allegations that Sonoma may have issued materially misleading business information to the investing public.   GlobeNewswire Inc
Nov 30, 2020
09:00PM EST  Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) on behalf of Sonoma stockholders. Our investigation concerns whether Sonoma has violated the federal securities laws and/or engaged in other unlawful business practices.   GlobeNewswire Inc
08:46PM EST  Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. (Sonoma or the Company) (NASDAQ: SNOA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Nov 25, 2020
11:20PM EST  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of   PR Newswire
08:26PM EST  The Portnoy Law Firm advises Sonoma Pharmaceuticals, Inc. ("Sonoma" or the "Company") (NASDAQ:SNOA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. The investigation focuses on news concerning the violation of securities laws.   GlobeNewswire Inc
Nov 24, 2020
08:47PM EST  ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against   PR Newswire
04:38PM EST  Sonoma Pharma S-3 Shows Registration For ~$63M Mixed Securities Shelf Offering   Benzinga
Nov 20, 2020
04:22PM EST  Sonoma Pharmaceuticals Q2 EPS $0.06 Up From $(0.91) YoY, Sales $5.80M Up From $4.97M YoY   Benzinga
04:21PM EST  Sonoma Pharmaceuticals Reports Second Quarter FY 2021 Financial Results   Business Wire
Sep 18, 2020
10:22AM EDT  Shares of Sonoma Pharmaceuticals, Inc. (SNOA) are rising over 16% on Friday morning. The company on Thursday evening announced that it received approval to sell Nanocyn Disinfectant & Sanitizer in Canada.   RTTNews
10:17AM EDT  Mid-Morning Market Update: Markets Mixed; US Consumer Sentiment Rises In September   Benzinga
Sep 17, 2020
07:01PM EDT  After Market Hours: Sonoma Pharmaceuticals, Ashford   RTTNews
04:07PM EDT  Sonoma Pharma, MicroSafe Report Health Canada Authorization Of Nanocyn Disinfectant, Sanitizer To Be Sold In Canada As Hard-Surface Disinfectant Under COVID-19 Interim Measure   Benzinga
04:05PM EDT  Sonoma Pharmaceuticals and MicroSafe Group Announce that Health Canada Authorized Nanocyn(r) Disinfectant & Sanitizer to be Sold in Canada as a Hard-Surface Disinfectant under COVID-19 Interim Measure   Business Wire
Sep 9, 2020
04:12PM EDT  Sonoma Pharmaceuticals And Te Arai BioFarma Announce Launch Of Nasocyn Nasal Care And Oracyn Oral Care Products In Australia   Benzinga
04:10PM EDT  Sonoma Pharmaceuticals and Te Arai BioFarma Announce Launch of Two New Microcyn(r) Technology Products in Australia - Nasocyn(r) Nasal Care and Oracyn(r) Oral Care   Business Wire
Aug 14, 2020
05:10PM EDT  Sonoma Pharma Q1 EPS $0.54 Vs. $0.14 Year Ago   RTTNews
05:00PM EDT  Sonoma Pharmaceuticals Q1 EPS $0.02, Sales $7.30M Up From $4.71M YoY   Benzinga
04:59PM EDT  Sonoma Pharmaceuticals Reports First Quarter 2021 Financial Results   Business Wire
Jul 29, 2020
12:00PM EDT  Mid-Day Market Update: Nasdaq Surges Over 100 Points; Eastman Kodak Shares Spike Higher   Benzinga
10:19AM EDT  Mid-Morning Market Update: Markets Open Higher; General Motors Posts Narrower-Than-Expected Loss   Benzinga
09:55AM EDT  Shares of nano-cap Sonoma Pharmaceuticals, Inc. (SNOA) surged 70% on Wednesday morning following news that its Microsafe Disinfectant & Sanitizer passed Boeing and Airbus airline specifications.   RTTNews
Jul 28, 2020
04:13PM EDT  Sonoma Pharmaceuticals and MicroSafe Group Announce That Microsafe Disinfectant & Sanitizer Manufactured Using Sonoma's Microcyn Technology Successfully Passed Material Compatibility Testing For Both Airbus And Boeing Commercial Transport Aircraft   Benzinga
04:05PM EDT  Sonoma Pharmaceuticals and MicroSafe Group Announce That Microsafe(r) Disinfectant & Sanitizer Manufactured Using Sonoma's Microcyn(r) Technology Successfully Passed Material Compatibility Testing for Both Airbus and Boeing Commercial Transport Aircraft   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC